Clinical trial
Randomized Double-Blind Placebo-Controlled Pharmacodynamic Evaluation of ONO-5129 in Patients With Treatment Naive Type 2 Diabetes Mellitus
NCT00212641 is registered in ClinicalTrials.gov with Ono Pharma USA Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Double-Blind Placebo-Controlled Pharmacodynamic Evaluation of ONO-5129 in Patients With Treatment Naive Type 2 Diabetes Mellitus
- Lead sponsor
- Ono Pharma USA Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- Not reported
- Enrollment
- 105
- Sites
- 67
Conditions
As the registry lists them; a condition with its own page is linked.